incobotulinumtoxinA 200 UNT Injection
Managing this medication for someone you care for? Eleplan keeps diagnoses, medications and appointments in one plan.
Start free with EleplanClinical drug
incobotulinumtoxinA 200 UNT Injection
200 UNT · Injection · injection
A form of incobotulinumtoxinA →
incobotulinumtoxinA 200 UNT Injection. Strength, form, class, interactions & more.

Active ingredient
Classification
Acetylcholine Release Inhibitor
Drug interactions
XEOMIN has several drug interactions that may potentiate its effects or lead to excessive weakness.
- moderateaminoglycosides — may potentiate the effect of XEOMIN
- moderateother agents that interfere with neuromuscular transmission — may potentiate the effect of XEOMIN
- moderateanticholinergic drugs — may potentiate systemic anticholinergic effects
- unknownother botulinum neurotoxin products — excessive neuromuscular weakness may be exacerbated
- unknownmuscle relaxants — excessive weakness may be exaggerated
Real-world adverse events (FAERS)
Drug Ineffective1,785Off Label Use1,194Therapeutic Response Decreased695Injection Site Pain329Product Preparation Issue196Headache189Injection Site Swelling182Overdose180
Source: RxNorm + openFDA + RxClass + FAERS · 2026
Look up another medication